Chemopreventive effects of nobiletin and its colonic metabolites on colon carcinogenesis

Molecular Nutrition and Food Research

Volumn 59, Issue 12, 2015, Pages 2383-2394

  Wu, Xian ^a   Song, Mingyue ^a   Wang, Minqi ^a   Zheng, Jinkai ^a,b   Gao, Zili ^a   Xu, Fei ^a   Zhang, Guodong ^a   Xiao, Hang ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Chemoprevention; Colitis; Colon carcinogenesis; Metabolites; Nobiletin

Indexed keywords

3',4'-DIDEMETHYLNOBILETIN; 3'-DEMETHYLNOBILETIN; 4'-DEMETHYLNOBILETIN; ANTINEOPLASTIC AGENT; CYTOKINE; FLAVONE DERIVATIVE; NOBILETIN;

ANIMAL; APOPTOSIS; COLITIS; COLONIC NEOPLASMS; COMPLICATION; DRUG EFFECTS; HUMAN; INBRED MOUSE STRAIN; MALE; METABOLISM; NEOPLASMS, EXPERIMENTAL; ORAL DRUG ADMINISTRATION; PATHOLOGY; TUMOR CELL LINE;

ADMINISTRATION, ORAL; ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; COLITIS; COLONIC NEOPLASMS; CYTOKINES; FLAVONES; HUMANS; MALE; MICE, INBRED STRAINS; NEOPLASMS, EXPERIMENTAL;

EID: 84952769409     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500378     Document Type: Article

References (45)

1. Mantovani, A., Allavena, P., Sica, A., Balkwill, F., Cancer-related inflammation. Nature 2008, 454, 436-444.
2. Bernstein, C. N., Blanchard, J. F., Kliewer, E., Wajda, A., Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001, 91, 854-862.
3. Mehta, R. G., Murillo, G., Naithani, R., Peng, X., Cancer chemoprevention by natural products: how far have we come? Pharm. Res. 2010, 27, 950-961.
4. Li, S., Lo, C. Y., Ho, C. T., Hydroxylated polymethoxyflavones and methylated flavonoids in sweet orange (Citrus sinensis) peel. J Agric. Food Chem. 2006, 54, 4176-4185.
5. Murakami, A., Nakamura, Y., Torikai, K., Tanaka, T. et al., Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res. 2000, 60, 5059-5066.
6. Yoshigai, E., Machida, T., Okuyama, T., Mori, M. et al., Citrus nobiletin suppresses inducible nitric oxide synthase gene expression in interleukin-1beta-treated hepatocytes. Biochem. Biophys. Res. Commun. 2013, 439, 54-59.
7. Xiong, Y., Chen, D., Yu, C., Lv, B. et al., Citrus nobiletin ameliorates experimental colitis by reducing inflammation and restoring impaired intestinal barrier function. Mol. Nutr. Food Res. 2015, 59, 829-842.
8. Minagawa, A., Otani, Y., Kubota, T., Wada, N. et al., The citrus flavonoid, nobiletin, inhibits peritoneal dissemination of human gastric carcinoma in SCID mice. Jpn. J. Cancer Res. 2001, 92, 1322-1328.
9. Tang, M., Ogawa, K., Asamoto, M., Hokaiwado, N. et al., Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells. Cancer Sci. 2007, 98, 471-477.
10. Suzuki, R., Kohno, H., Murakami, A., Koshimizu, K. et al., Citrus nobiletin inhibits azoxymethane-induced large bowel carcinogenesis in rats. Biofactors 2004, 22, 111-114.
11. Miyamoto, S., Yasui, Y., Tanaka, T., Ohigashi, H. et al., Suppressive effects of nobiletin on hyperleptinemia and colitis-related colon carcinogenesis in male ICR mice. Carcinogenesis 2008, 29, 1057-1063.
12. Tang, M. X., Ogawa, K., Asamoto, M., Chewonarin, T. et al., Effects of nobiletin on PhIP-induced prostate and colon carcinogenesis in F344 rats. Nutr. Cancer 2011, 63, 227-233.
13. Mulvihill, E. E., Assini, J. M., Lee, J. K., Allister, E. M. et al., Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance. Diabetes 2011, 60, 1446-1457.
14. Lotito, S. B., Zhang, W. J., Yang, C. S., Crozier, A. et al., Metabolic conversion of dietary flavonoids alters their anti-inflammatory and antioxidant properties. Free Radic. Biol. Med. 2011, 51, 454-463.
15. Yang, M., Cheng, C., Yang, J., Guo, D. A., Metabolite profiling and characterization for medicinal herbal remedies. Curr. Drug Metab. 2012, 13, 535-557.
16. Setchell, K. D., Clerici, C., Equol: pharmacokinetics and biological actions. J. Nutr. 2010, 140, 1363S-1368S.
17. Touil, Y. S., Auzeil, N., Boulinguez, F., Saighi, H. et al., Fisetin disposition and metabolism in mice: Identification of geraldol as an active metabolite. Biochem. Pharmacol. 2011, 82, 1731-1739.
18. Reeves, P. G., Components of the AIN-93 diets as improvements in the AIN-76A diet. J. Nutr. 1997, 127, 838S-841S.
19. Oki, E., Sakaguchi, Y., Toh, Y., Oda, S. et al., Induction of apoptosis in human tumour xenografts after oral administration of uracil and tegafur to nude mice bearing tumours. Br. J. Cancer 1998, 78, 625-630.
20. Xiao, H., Hao, X., Simi, B., Ju, J. et al., Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats. Carcinogenesis 2008, 29, 113-119.
21. Pascal, R. R., Dysplasia and early carcinoma in inflammatory bowel disease and colorectal adenomas. Human Pathol. 1994, 25, 1160-1171.
22. Li, H., Wu, W. K., Li, Z. J., Chan, K. M. et al., 2, 3′, 4, 4′, 5′-Pentamethoxy-trans-stilbene, a resveratrol derivative, inhibits colitis-associated colorectal carcinogenesis in mice. Br. J. Pharmacol. 2010, 160, 1352-1361.
23. Guo, S., Qiu, P., Xu, G., Wu, X. et al., Synergistic anti-inflammatory effects of nobiletin and sulforaphane in lipopolysaccharide-stimulated RAW 264.7 cells. J. Agric. Food Chem. 2012, 60, 2157-2164.
24. Chiou, Y. S., Ma, N. J., Sang, S., Ho, C. T. et al., Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently suppresses dextran sulfate sodium-induced colitis and colon tumorigenesis in mice. J. Agric. Food Chem. 2012, 60, 3441-3451.
25. Livak, K. J., Schmittgen, T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25, 402-408.
26. Zheng, J., Song, M., Dong, P., Qiu, P. et al., Identification of novel bioactive metabolites of 5-demethylnobiletin in mice. Mol. Nutr. Food Res. 2013, 57, 1999-2007.
27. Zheng, J., Bi, J., Johnson, D., Sun, Y. et al., Analysis of 10 Metabolites of Polymethoxyflavones with High Sensitivity by Electrochemical Detection in High-Performance Liquid Chromatography. J. Agric. Food Chem. 2015, 63, 509-516.
28. Li, S., Wang, Z., Sang, S., Huang, M. T., Ho, C. T., Identification of nobiletin metabolites in mouse urine. Mol. Nutr. Food. Res. 2006, 50, 291-299.
29. Li, S., Sang, S., Pan, M. H., Lai, C. S. et al., Anti-inflammatory property of the urinary metabolites of nobiletin in mouse. Bioorg. Med. Chem. Lett. 2007, 17, 5177-5181.
30. Qiu, P., Dong, P., Guan, H., Li, S. et al., Inhibitory effects of 5-hydroxy polymethoxyflavones on colon cancer cells. Mol. Nutr. Food Res. 2010, 54 (Suppl 2), S244-S252.
31. Xiao, H., Zhang, Q., Lin, Y., Reddy, B. S. et al., Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells. Int. J. Cancer 2008, 122, 2115-2124.
32. Charoensinphon, N., Qiu, P., Dong, P., Zheng, J. et al., 5-Demethyltangeretin inhibits human nonsmall cell lung cancer cell growth by inducing G2/M cell cycle arrest and apoptosis. Mol. Nutr. Food Res. 2013, 57, 2103-2111.
33. Clapper, M. L., Cooper, H. S., Chang, W. C., Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol. Sin. 2007, 28, 1450-1459.
34. De Robertis, M., Massi, E., Poeta, M. L., Carotti, S. et al., The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies. J. Carcinog. 2011, 10, 9.
35. Kurki, P., Vanderlaan, M., Dolbeare, F., Gray, J. et al., Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp. Cell Res. 1986, 166, 209-219.
36. McKay, J. A., Douglas, J. J., Ross, V. G., Curran, S. et al., Analysis of key cell-cycle checkpoint proteins in colorectal tumours. J. Pathol. 2002, 196, 386-393.
37. Pan, M. H., Ho, C. T., Chemopreventive effects of natural dietary compounds on cancer development. Chem. Soc. Rev. 2008, 37, 2558-2574.
38. Ouyang, L., Shi, Z., Zhao, S., Wang, F. T. et al., Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2012, 45, 487-498.
39. Takahashi, M., Wakabayashi, K., Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci. 2004, 95, 475-480.
40. Terzic, J., Grivennikov, S., Karin, E., Karin, M., Inflammation and colon cancer. Gastroenterology 2010, 138, 2101-2114, e2105.
41. Nielsen, S. E., Breinholt, V., Cornett, C., Dragsted, L. O., Biotransformation of the citrus flavone tangeretin in rats. Identification of metabolites with intact flavane nucleus. Food Chem. Toxicol. 2000, 38, 739-746.
42. Lo, Y. H., Pan, M. H., Li, S., Yen, J. H. et al., Nobiletin metabolite, 3′, 4′-dihydroxy-5, 6, 7, 8-tetramethoxyflavone, inhibits LDL oxidation and down-regulates scavenger receptor expression and activity in THP-1 cells. Biochim. Biophys. Acta 2010, 1801, 114-126.
43. Owa, T., Yoshino, H., Yoshimatsu, K., Nagasu, T., Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents. Curr. Med. Chem. 2001, 8, 1487-1503.
44. Fesik, S. W., Promoting apoptosis as a strategy for cancer drug discovery. Nat. Rev. Cancer 2005, 5, 876-885.
45. Oliver, F. J., de la Rubia, G., Rolli, V., Ruiz-Ruiz, M. C. et al., Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J. Biol. Chem. 1998, 273, 33533-33539.